Key facts
- This page summarizes Eric Dobmeier's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 Jun 2022, 16:48.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
These restricted stock units shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.
Footnote F2
The option shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.